EARNEST Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

EARNEST Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,767	Closed	-$117K	–	1173
2023 Q2	$117K	Sell	2,767 -2,590,741	-100%	-$105M	﹤0.01%	297
2023 Q1	$92.4M	Buy	2,593,508 +1,093,222	+73%	+$39.7M	0.53%	82
2022 Q4	$55M	Buy	1,500,286 +8,658	+0.6%	+$342K	0.34%	118
2022 Q3	$70.3M	Buy	1,491,628 +35,533	+2%	+$2.3M	0.47%	90
2022 Q2	$104M	Buy	1,456,095 +295,380	+25%	+$21.6M	0.7%	57
2022 Q1	$94M	Buy	1,160,715 +22,704	+2%	+$1.92M	0.56%	73
2021 Q4	$117M	Buy	1,138,011 +38,663	+4%	+$3.71M	0.67%	52
2021 Q3	$96.2M	Buy	1,099,348 +22,015	+2%	+$1.99M	0.59%	64
2021 Q2	$96.4M	Buy	1,077,333 +50,793	+5%	+$4.29M	0.57%	73
2021 Q1	$77.9M	Buy	1,026,540 +124,242	+14%	+$9.37M	0.47%	85
2020 Q4	$61.5M	Buy	902,298 +237,282	+36%	+$14.8M	0.42%	98
2020 Q3	$35.4M	Buy	665,016 +268,365	+68%	+$16M	0.31%	116
2020 Q2	$23.1M	Sell	396,651 -35,397	-8%	-$1.9M	0.22%	127
2020 Q1	$17M	Buy	432,048 +1,372	+0.3%	+$80.2K	0.19%	135
2019 Q4	$25.6M	Buy	430,676 +1,509	+0.4%	+$81.1K	0.2%	135
2019 Q3	$22.8M	Sell	429,167 -4,871	-1%	-$250K	0.21%	129
2019 Q2	$22.2M	Buy	434,038 +40,424	+10%	+$1.88M	0.2%	134
2019 Q1	$20.4M	Sell	393,614 -174,412	-31%	-$8.46M	0.19%	136
2018 Q4	$22.4M	Buy	568,026 +3,693	+0.7%	+$172K	0.24%	126
2018 Q3	$29.1M	Sell	564,333 -16,608	-3%	-$813K	0.26%	120
2018 Q2	$27.2M	Sell	580,941 -7,980	-1%	-$330K	0.25%	121
2018 Q1	$20.9M	Buy	+588,921	New	+$23.1M	0.2%	135

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $88.9B AUM 38.03% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $46.7B AUM 50.59% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

EARNEST Partners's SYNH Position: Q3 2023 in Review

EARNEST Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 2,767 shares — an estimated $117K sold.

EARNEST Partners first reported a position in SYNH in Q1 2018 and held it in 22 quarters. The position peaked at $117M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

EARNEST Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
EARNEST Partners sold 2,767 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $117K.
EARNEST Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2018 and held it in 22 quarters.
EARNEST Partners's Syneos Health, Inc. Class A Common Stock position peaked at $117M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on EARNEST Partners's 13F filing for Q3 2023, filed 14 Nov 2023.